Miika Mehine
- Obstetrics and Gynecology top 0.5%
- Uterine Myomas and Treatments 14
- Gynecological conditions and treatments 5
- Endometrial and Cervical Cancer Treatments 4
- Reproductive Medicine top 0.5%
- Endometriosis Research and Treatment 7
- Ovarian cancer diagnosis and treatment 3
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 4
- Pathology and Forensic Medicine top 10%
-
- Sarcoma Diagnosis and Treatment 4
- Renal cell carcinoma treatment 3
- Co-authors
- Pia VahteristoNetta MäkinenLauri A. AaltonenHanna-Riikka HeinonenJari SjöbergEevi KaasinenRiku KatainenRalf Bützow
- Journals
- Science (1 paper)New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- FinlandUnited StatesSweden
In The Last Decade
Miika Mehine
28 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Obstetrics and Gynecology 977
- Reproductive Medicine 831
- Cancer Research 196
- Pathology and Forensic Medicine 162
- Pulmonary and Respiratory Medicine 196
Countries citing papers authored by Miika Mehine
This map shows the geographic impact of Miika Mehine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miika Mehine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miika Mehine more than expected).
Fields of papers citing papers by Miika Mehine
This network shows the impact of papers produced by Miika Mehine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miika Mehine. The network helps show where Miika Mehine may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miika Mehine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 34 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 63 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 6 | |
| 10 | Multiple copies of rhodopsin as a novel cause of autosomal dominant retinitis pigmentosa | 2019 | 1 |
| 11 | A whole exome sequencing-based panel assay with boosted clinical content generates a high diagnostic yield in patients with inherited eye diseases | 2019 | 1 |
| 12 | 2017 | 32 | |
| 13 | 2016 | 157 | |
| 14 | 2016 | 36 | |
| 15 | 2015 | 17 | |
| 16 | 2014 | 149 | |
| 17 | 2014 | 79 | |
| 18 | 2013 | 252 | |
| 19 | 2012 | 87 | |
| 20 | MED12 , the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomasbreakdown → | 2011 | 470 |
About Miika Mehine
Miika Mehine is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Cancer Research, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Uterine Myomas and Treatments (14 papers), Endometriosis Research and Treatment (7 papers), Gynecological conditions and treatments (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), Sarcoma Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers), Renal cell carcinoma treatment (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Obstetrics and Gynecology (977 citations), Reproductive Medicine (831 citations) and Cancer Research (196 citations). Miika Mehine has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Pia Vahteristo, Netta Mäkinen, Lauri A. Aaltonen, Hanna-Riikka Heinonen, Jari Sjöberg, Eevi Kaasinen, Riku Katainen, Ralf Bützow, Massimiliano Gentile and Kati Kämpjärvi. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.